{"nct_id":"NCT01101594","title":"A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma","status":"TERMINATED","status_verified_date":"2020-03","start_date":"2010-07","start_date_type":null,"primary_completion_date":"2013-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-07","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}